Loss per Share

Loss per share were computed as follows (in millions, except share data):



	Three Months Ended						Six Months Ended
	July 2, 2016 Restated			July 4, 2015			July 2, 2016 Restated			July 4, 2015
Weighted average shares:
Basic weighted average shares outstanding	51,533,236			50,917,161			51,405,373			50,798,238
Effect of dilutive securities outstanding	—			—			—			—
Diluted weighted average and equivalent shares outstanding	51,533,236			50,917,161			51,405,373			50,798,238
Net loss	$	(45	)	$	(77	)	$	(71	)	$	(102	)
Basic per share amounts:
Basic weighted average shares outstanding	51,533,236			50,917,161			51,405,373			50,798,238
Per share amount	$	(0.88	)	$	(1.50	)	$	(1.38	)	$	(2.00	)
Diluted per share amounts:
Diluted weighted average shares outstanding	51,533,236			50,917,161			51,405,373			50,798,238
Per share amount	$	(0.88	)	$	(1.50	)	$	(1.38	)	$	(2.00	)

Anti-dilutive securities consist primarily of stock appreciation rights (SARs) with an exercise price greater than the average market closing price of the Class A common stock.

Due to net losses in both the second quarter and first half of 2016 and 2015, options, awards and warrants were anti-dilutive and therefore excluded from the earnings per share calculation. These excluded outstanding options, awards and warrants are as follows:



	Three Months Ended		Six Months Ended
	July 2, 2016	July 4, 2015	July 2, 2016	July 4, 2015
Potentially dilutive shares	1,313,435	1,152,707	1,356,668	1,018,482